LYVE1 and cancer: Although the above protein markers are associated with lymphangiogenesis in GC, only two proteins, LYVE1 and podoprotein, have been routinely monitored in cancer in the past 10 years to identify lymphatic vessels and have been used for immunohistochemistry or immunofluorescence.